[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-158575-es":3,"doc-seo-158575-110":29,"detail-sidebar-cat-0-es-110":90},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":20,"language":21,"language_code":22,"site_id":23,"html_lang":22,"table_of_contents":24,"faqs":25,"seo_title":26,"seo_description":14,"update_tm":27,"read_time":28},158575,1099514068035,"Ezra","https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c",40,"Salud y Atención Médica","Cápsula de liberación inmediata de deucrictibant oral para el tratamiento a demanda de ataques de angioedema hereditario - Resultados del ensayo de fase 3 RAPIDe-3","El documento resume los resultados del ensayo clínico de fase 3 RAPIDe-3 sobre deucrictibant oral en cápsula de liberación inmediata, evaluado para el tratamiento a demanda de los ataques de angioedema hereditario. Se presenta una lista extensa de investigadores y afiliaciones de múltiples centros internacionales, lo que refleja un estudio multicéntrico. La información clave se centra en el objetivo terapéutico del fármaco para controlar episodios agudos, respaldado por la estructura del reporte del ensayo fase 3.","Cápsula de liberación inmediata de deucrictibant oral para el tratamiento a demanda de ataques de angioedema hereditario: 2608  \nResultados del ensayo de fase 3 RAPIDe-3  \nRicardo D. Zwiener 1, Marc A. Riedl2, Philip H. Li3, Adil Adatia4, Mauro Cancian 5, Marcin Stobiecki 6, Anna Valerieva7, Anete S. Grumach8, William R. Lumry9, Daniel F. Soteres 10, Nicholas Brodszki 11, Natalia L. Fili 12, Roman Hakl13, Hye-Ryun Kang14,15,16,17, Gul Karakaya 18, Birger Kränke 19, H. Henry Li20, Jonny Peter21,22, Andreas Recke23, Raffi Tachdjian24, Paola Triggianese25, Andrea Zanichelli26,27, John Anderson28, Emel Aygören-Pürsün29,  \nTimothy J. Craig30,31, Henriette Farkas32, Francesco Giardino33, Pedro Giavina-Bianchi34, Sujeong Kim35, Tamar Kinaciyan36, Inmaculada Martinez-Saguer37, Francesca Perego38, Karl V. Sitz39, Maria Staevska7, H. James Wedner40, Rafael H. Zaragoza-Urdaz41, Asli Gelincik42, Francesco Arcoleo43, Rand Arnaout44, Alan P. Baptist45, Régis Albuquerque Campos46, Anthony D. Dorr47, Mariana Paes Leme Ferriani48, Atsushi Fukunaga49, Delphine Gobert 50, Padmalal Gurugama51, Michihiro Hide52, David I. Hong 53, Eisuke Inage 54, Joshua S. Jacobs 55, Constance H. Katelaris 56, Lucy Leeman 57, Ramón Lleonart 58, Markus Magerl 59,60, Michael E. Manning 61, Satoshi Mano 62, Seido Ooka 63, Cristina J. Ramos64, Jinzhong Liu 65, Li Zhu 65, Joan Mendivil 66, Umar Katbeh 66, Giorgio Giannattasio 66, Rafael Crabbé 67, Ming Yu 65, Anne Lesage68, Peng Lu65, Danny M. Cohn 69  \n1 Hospital Universitario Austral, Buenos Aires, Argentina; 2 University of California San Diego, La Jolla, CA, USA; 3 Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China; 4 University of Alberta, Edmonton, AB, Canada; 5Azienda Ospedale Università di Padova, Padua, Italy; 6Jagiellonian University Medical College, Kraków, Poland; 7 Medical University of Sofia, Sofia, Bulgaria; 8 Centro Universitario FMABC, São Paulo, Brazil; 9AARA Research Center, Dallas, TX, USA; 10Asthma & Allergy Associates and Research Center, P. C., Colorado Springs; University CO Health Sciences Center, Aurora, CO, USA; 11 Children's Hospital, Skåne University Hospital, Lund, Sweden; 12 Hospital Público Materno Infantil, Salta, Argentina; 13St. Anne's University Hospital in Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; 14Seoul National University College of Medicine, Seoul, South Korea; 15Seoul National University Hospital, Seoul, South Korea; 16 Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, South Korea; 17 Korean Drug Allergy Research Consortium, Seoul, South Korea; 18 Hacettepe University Faculty of Medicine, Ankara, Türkiye; 19 Medical University of Graz, Graz, Austria; 20 Institute for Asthma and Allergy, Chevy Chase, MD, USA; 21 Groote Schuur Hospital, Cape Town, South Africa; 22 University of Cape Town and Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa; 23 University of Lübeck, Lübeck, Germany; 24 University of California at Los Angeles, Los Angeles, CA, USA; 25 University of Rome Tor Vergata, Rome, Italy; 26 Universita degli Studi di Milano, Milan, Italy; 27 I. R. C. C.S. Policlinico San Donato, Milan, Italy; 28AllerVie Health, Clinical Research Center of Alabama, Birmingham, AL, USA; 29 Goethe University Frankfurt, Frankfurt am Main, Germany; 30 Penn State University, Hershey, PA, USA; 31Vinmec-VinUni Institute of Immunology, Vinmec Hospital, Times City, Vietnam, and Vin University, Hanoi, Vietnam; 32 Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Budapest, Hungary; 33A. O. U. Policlinico “G. Rodolico-San Marco”, Catania, Italy; 34 Prof. Livre Docente Associado-Disciplina de Imunologia Clínica e Alergia da FMUSP, Visiting Professor da Harvard Medical School 2012-14, Editor dos Arquivos de Asma, Alergia e Imunologia, Diretor da World Allergy Organization, São Paulo, Brazil; 35School of Medicine, Kyungpook National Uni","cbCaibvVsBhCWfRZ","https://ap.wps.com/l/cbCaibvVsBhCWfRZ","pdf",254571,1,"Spanish","es",110,"# Resultados del ensayo de fase 3 RAPIDe-3\n## Cápsula oral de liberación inmediata de deucrictibant\n## Tratamiento a demanda de ataques de angioedema hereditario\n## Autores e instituciones participantes","[{\"question\":\"¿Qué evalúa el ensayo RAPIDe-3 en relación con el angioedema hereditario?\",\"answer\":\"Evalúa resultados del ensayo de fase 3 del deucrictibant oral en cápsula de liberación inmediata para el tratamiento a demanda de ataques de angioedema hereditario.\"},{\"question\":\"¿Cómo se administra el deucrictibant según el título del documento?\",\"answer\":\"Se administra como una cápsula oral de liberación inmediata, indicada para tratar episodios bajo demanda.\"},{\"question\":\"¿Qué indica la sección de autores e instituciones?\",\"answer\":\"Muestra que el estudio reúne un equipo multicéntrico con participantes de múltiples hospitales y universidades en distintos países.\"}]","Cápsula de liberación inmediata de deucrictibant oral para el tratamiento a demanda de ataques de angioedema hereditario - Resultados del ensayo de fase 3 RAPIDe-3 | PDF",1788005095,2,{"code":4,"msg":30,"data":31},"ok",{"site_id":23,"language":22,"slug":32,"title":13,"keywords":33,"description":14,"schema_data":34,"social_meta":85,"head_meta":87,"extra_data":89,"updated_unix":27},"immediate-release-oral-deucrictibant-capsule-for-on-demand-treatment-of-hereditary-angioedema-attacks-results-from-the-phase-3-trial-rapide-3","",{"@graph":35,"@context":84},[36,52,67],{"@type":37,"itemListElement":38},"BreadcrumbList",[39,43,46,49],{"item":40,"name":41,"@type":42,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":44,"name":45,"@type":42,"position":28},"https://docshare.wps.com/es/document/","Document",{"item":47,"name":12,"@type":42,"position":48},"https://docshare.wps.com/es/document/salud-y-atención-médica/",3,{"item":50,"name":13,"@type":42,"position":51},"https://docshare.wps.com/es/document/immediate-release-oral-deucrictibant-capsule-for-on-demand-treatment-of-hereditary-angioedema-attacks-results-from-the-phase-3-trial-rapide-3/158575/",4,{"url":50,"name":13,"@type":53,"author":54,"headline":13,"publisher":56,"fileFormat":59,"inLanguage":22,"description":14,"dateModified":60,"datePublished":61,"encodingFormat":59,"isAccessibleForFree":62,"interactionStatistic":63},"DigitalDocument",{"name":9,"@type":55},"Person",{"url":40,"name":57,"@type":58},"DocShare","Organization","application/pdf","2026-09-10","2026-08-29",true,{"@type":64,"interactionType":65,"userInteractionCount":20},"InteractionCounter",{"@type":66},"ViewAction",{"@type":68,"mainEntity":69},"FAQPage",[70,76,80],{"name":71,"@type":72,"acceptedAnswer":73},"¿Qué evalúa el ensayo RAPIDe-3 en relación con el angioedema hereditario?","Question",{"text":74,"@type":75},"Evalúa resultados del ensayo de fase 3 del deucrictibant oral en cápsula de liberación inmediata para el tratamiento a demanda de ataques de angioedema hereditario.","Answer",{"name":77,"@type":72,"acceptedAnswer":78},"¿Cómo se administra el deucrictibant según el título del documento?",{"text":79,"@type":75},"Se administra como una cápsula oral de liberación inmediata, indicada para tratar episodios bajo demanda.",{"name":81,"@type":72,"acceptedAnswer":82},"¿Qué indica la sección de autores e instituciones?",{"text":83,"@type":75},"Muestra que el estudio reúne un equipo multicéntrico con participantes de múltiples hospitales y universidades en distintos países.","https://schema.org",{"og:url":50,"og:type":86,"og:title":13,"og:site_name":57,"og:description":14},"article",{"robots":88,"canonical":50},"index,follow",{"doc_id":7,"site_id":23},{"code":4,"msg":5,"data":91},[92,97,101,105,109,113,117,121,125,127],{"id":93,"doc_module":4,"doc_module_name":45,"category_name":94,"show_sort_weight":95,"slug":96},39,"Cómic",60,"comic",{"id":98,"doc_module":4,"doc_module_name":45,"category_name":99,"show_sort_weight":95,"slug":100},43,"Estilo de Vida","lifestyle",{"id":102,"doc_module":4,"doc_module_name":45,"category_name":103,"show_sort_weight":95,"slug":104},38,"Examen","exam",{"id":106,"doc_module":4,"doc_module_name":45,"category_name":107,"show_sort_weight":95,"slug":108},44,"General","general",{"id":110,"doc_module":4,"doc_module_name":45,"category_name":111,"show_sort_weight":95,"slug":112},41,"Investigación e Informes","research-report",{"id":114,"doc_module":4,"doc_module_name":45,"category_name":115,"show_sort_weight":95,"slug":116},37,"Literatura","literature",{"id":118,"doc_module":4,"doc_module_name":45,"category_name":119,"show_sort_weight":95,"slug":120},22,"Relatos y Novelas","story-novel",{"id":122,"doc_module":4,"doc_module_name":45,"category_name":123,"show_sort_weight":95,"slug":124},42,"Religión y Espiritualidad","religion-spirituality",{"id":11,"doc_module":4,"doc_module_name":45,"category_name":12,"show_sort_weight":95,"slug":126},"healthcare",{"id":128,"doc_module":4,"doc_module_name":45,"category_name":129,"show_sort_weight":95,"slug":130},24,"Tecnología","technology"]